Issue 11, 2019

Radiosynthesis and preliminary in vivo evaluation of 18F-labelled glycosylated duramycin peptides for imaging of phosphatidylethanolamine during apoptosis

Abstract

Duramycin derivatives incorporating an [18F]-labelled prosthetic group and one or two hydrophilic sugar amino acid moieties have been prepared as potential tracers for imaging of phosphatidylethanolamine during apoptosis. [18F]FP-digalacto-duramycin exhibited a low Log D, high renal clearance and low background activity and is a promising radiotracer for tracking apoptosis in vivo.

Graphical abstract: Radiosynthesis and preliminary in vivo evaluation of 18F-labelled glycosylated duramycin peptides for imaging of phosphatidylethanolamine during apoptosis

Supplementary files

Article information

Article type
Research Article
Submitted
09 juil. 2019
Accepted
11 sept. 2019
First published
25 sept. 2019

Med. Chem. Commun., 2019,10, 1930-1934

Radiosynthesis and preliminary in vivo evaluation of 18F-labelled glycosylated duramycin peptides for imaging of phosphatidylethanolamine during apoptosis

M. B. Haskali, D. Denoyer, P. D. Roselt, R. J. Hicks and C. A. Hutton, Med. Chem. Commun., 2019, 10, 1930 DOI: 10.1039/C9MD00354A

To request permission to reproduce material from this article, please go to the Copyright Clearance Center request page.

If you are an author contributing to an RSC publication, you do not need to request permission provided correct acknowledgement is given.

If you are the author of this article, you do not need to request permission to reproduce figures and diagrams provided correct acknowledgement is given. If you want to reproduce the whole article in a third-party publication (excluding your thesis/dissertation for which permission is not required) please go to the Copyright Clearance Center request page.

Read more about how to correctly acknowledge RSC content.

Spotlight

Advertisements